Myocardial Production of Aldosterone and Corticosterone in the Rat

PHYSIOLOGICAL REGULATION*

Abstract

Increasing evidence suggests that mineralo- and glucocorticoids modulate cardiovascular homeostasis via the effects of circulating components generated within the adrenals but also through local synthesis. The aim of this study was to assess the existence of such a steroidogenic system in heart.

Using the quantitative reverse transcriptase-polymerase chain reaction, the terminal enzymes of corticosterone and aldosterone synthesis (11β-hydroxylase and aldosterone synthase, respectively) were detected in the rat heart. This pathway was shown to be physiologically active, since production of aldosterone, corticosterone, and their precursor, deoxycorticosterone, was detected in both the homogenate and perfusate of isolated rat hearts using radioimmunoassay after Celite column chromatography. Perfusion of angiotensin II or adrenocorticotropin for 3 h increased aldosterone and corticosterone production and decreased deoxycorticosterone, suggesting that aldosterone and corticosterone are formed within the isolated heart from a locally present substrate.

Chronic regulation of this intracardiac system was then examined. As in adrenals cardiac 11β-hydroxylase and aldosterone-synthase mRNAs were independently regulated by 1 week’s treatment with either low sodium and high potassium diet (which increased aldosterone synthase mRNA level only), angiotensin II (which raised level of both mRNAs), or adrenocorticotropin (which stimulated the 11β-hydroxylase gene exclusively). Changes in cardiac steroid levels during treatment were not directly related to their plasma levels suggesting independent regulating mechanisms. This study, therefore, provides the first evidence for the existence of an endocrine cardiac steroidogenic system in rat heart and emphasizes its potential physiological and pathological relevance.

Footnotes

  • * This study was supported by grants from INSERM.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • Recipient of a fellowship from the Ministère de la Recherche et de l’Enseignement Supérieur.

  • § Present address: Service de Biochimie, CHU Pitié-Salpétrière, 75634, Paris Cedex 13, France.

  • To whom correspondence should be addressed: U127-INSERM, Hôpital Lariboisière, 41 Bd de la Chapelle, 75475 Paris Cedex 10, France. Tel.: 33-0142858065; Fax: 33-0148742315; E-mail:claude.delcayre{at}inserm.lrb.ap-hop-paris.fr.

  • 1 The abbreviations used are: OHase, hydroxylase; DOC, 11-deoxycorticosterone; ACTH, adrenocorticotropic hormone; Aldo, aldosterone; Ang, angiotensin; RT, reverse transcriptase; PCR, polymerase chain reaction; bp, base pair(s).

    • Received July 23, 1997.
    • Revision received November 17, 1997.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement